Solengepras shows strong potential as an adjunctive therapy for Parkinson’s, offering a novel, well-tolerated option with ...

Researchers have successfully developed nerve grafts, currently being trialed as a treatment for Parkinson’s disease, that ...

See α-Synuclein. Candidate tracer SY08 detects α-synuclein deposits in the brainstem (right) and parietal cortex (left) of people with Parkinson’s (middle) and dementia with Lewy bodies (bottom), but ...

Fixed and flexible doses of tavapadon significantly improved motor function compared with placebo in patients with Parkinson’s disease, according to a pair of phase 3 trials presented at the American ...

Chronic constipation can be an early sign of Parkinson's disease, appearing even years before the onset of motor symptoms, and is a common non-motor symptom associated with the condition. The ...

The act of ordering a coffee a dopaminergic reward system, while even the anticipation of waiting for a coffee or a tea can ...

A leading neurologist shares the science of how the ritual of ordering a coffee can make us happier and more motivated before even taking the ...

In Parkinson’s disease (PD), damaged mitochondria build up in the dopaminergic system of the substantia nigra, partly due to impaired mitochondrial autophagy (mitophagy) and autophagosome accumulation ...

There's no cure for Parkinson's, but there are some medications that can help control symptoms. Also, doctors say aerobic exercise may slow down the onset of symptoms and improve quality of life.

In connection with the financing, Serina issued 965,250 shares of convertible preferred stock at $5.18 per share, equivalent to the closing price of its common stock on April 7, 2025.

Parkinson’s disease (PD) is a neurodegenerative disease of the central nervous system characterized by the loss of dopaminergic neurons in the substantia nigra and the abnormal aggregation of ...

CVN293 was generally well-tolerated in healthy volunteers with evidence of robust brain penetration, supporting utility of KCNK13 inhibitors for ...